ideaya - Robuta Search

https://www.biospace.com/drug-development/ideaya-and-serviers-eye-cancer-drug-heads-to-fda-after-delivering-best-in-class-efficacy IDEAYA and Servier’s eye cancer drug heads to FDA after delivering ‘best in class’ efficacy -... Apr 13, 2026 - Darovasertib, in combination with crizotinib, more than doubled progression-free survival in a registrational trial, leading Truist analysts to declare a... eye cancer ideaya drug heads fda https://www.biospace.com/employer/399645/ideaya-biosciences IDEAYA Biosciences - BioSpace ideaya biosciences biospace https://www.biopharmadive.com/news/novo-openai-regeneron-radiopharmaceuticals-ideaya-neomorph-gsk/817278/ Novo teams with OpenAI; Ideaya gets muted response to eye drug data | BioPharma Dive Apr 13, 2026 - Novo intends to “fully integrate” AI capabilities across its operations. Elsewhere, Regeneron made its first foray into radiopharmaceuticals and a GSK cancer... muted response drug data biopharma dive novo teams https://www.biospace.com/press-releases/ideaya-biosciences-announces-first-patient-in-for-phase-1-trial-of-ide574-a-potential-first-in-class-dual-inhibitor-of-kat6-7-to-target-multiple-solid-tumor-indications-including-breast-prostate-crc-and-lung-cancer IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In... biosciences announces first patient phase 1 ideaya trial